Our Blog

 

Newsletter Volume 5; Issue 4

By Kevin C Maki PhD and Mary R Dicklin PhD | Oct 6, 2021 | 0 Comments

MB Clinical Research Newsletter Volume 5; Issue 4 (Click here)

Read More

Newsletter Volume 5; Issue 3

By Kevin C Maki PhD and Mary R Dicklin PhD | Jul 15, 2021 | 0 Comments

MB Clinical Research Newsletter Volume 5; Issue 2 (Click here)

Read More

Newsletter Volume 5; Issue 2

By Kevin C Maki PhD and Mary R Dicklin PhD | Mar 30, 2021 | 0 Comments

MB Clinical Research Newsletter Volume 5; Issue 2 (Click here)

Read More

Newsletter Volume 5; Issue 1

By Kevin C Maki PhD and Mary R Dicklin PhD | Jan 7, 2021 | 0 Comments

MB Clinical Research Newsletter Volume 5; Issue 1 (Click here)

Read More

Newsletter Volume 1; Issue 3

By Kevin C Maki PhD and Mary R Dicklin PhD | Nov 11, 2020 | 0 Comments

MB Clinical Research Newsletter Volume 4; Issue 3 (Click here)

Read More

SARS-CoV-2/Covid-19 Pandemic Update and Commentary

By Kevin Maki PhD | Apr 14, 2020 | 0 Comments

SARS-CoV-2/Covid-19 Pandemic Update and Commentary By Kevin C. Maki, PhD, CLS, FNLA   Comments from our Chief Scientist, Epidemiologist Kevin C. Maki, PhD as of April 11, 2020   The toll produced by the global pandemic of novel coronavirus (SARS-CoV-2), which causes the Covid-19 disease, is enormous, both in human and economic terms.  I am

Read More

Comparing the Effects of Consuming Egg-based Breakfast Meals, versus Higher Carbohydrate Breakfast Meals, on Cardiometabolic Risk Factors

By Mary R Dicklin PhD Kevin Maki PhD | Apr 14, 2020 | 0 Comments

Comparing the Effects of Consuming Egg-based Breakfast Meals, versus Higher Carbohydrate Breakfast Meals, on Cardiometabolic Risk Factors By Mary R Dicklin, PhD and Kevin C Maki, PhD, CLS, FNLA   Recently, our group conducted a clinical trial that compared the effects of consuming egg-based breakfast meals with non-egg, higher carbohydrate breakfast meals on cardiometabolic risk

Read More

Cardiovascular Safety of Oral Semaglutide in Patients with Type 2 Diabetes

By Heather Nelson Cortes PhD and Kevin C Maki PhD | Aug 22, 2019 | 0 Comments

Cardiovascular Safety of Oral Semaglutide in Patients with Type 2 Diabetes By Heather Nelson Cortes, PhD and Kevin C Maki, PhD Cardiovascular disease (CVD) is the leading cause of mortality in patients with type 2 diabetes (T2D), therefore it is required that all new glucose-lowering therapies demonstrate no increase in cardiovascular risk with treatment.1  Glucagon-like-peptide-1

Read More

The Effects of Nutritional Supplements and Dietary Interventions on All-Cause Mortality and Cardiovascular Outcomes

By Aly Becraft MS and Kevin C Maki PhD | Aug 12, 2019 | 0 Comments

The Effects of Nutritional Supplements and Dietary Interventions on All-Cause Mortality and Cardiovascular Outcomes By Aly Becraft, MS and Kevin C Maki, PhD   Despite scientific uncertainty surrounding the benefits of dietary supplements, many U.S. adults use them, along with various dietary interventions, with the belief that they will improve their overall health (1).  Khan

Read More

Therapeutic potential of selective peroxisome proliferator-activated receptor alpha modulators (SPPARMα) for management of patients with atherogenic dyslipidemia

By Heather Nelson Cortes PhD and Kevin C Maki PhD | Jul 10, 2019 | 0 Comments

Therapeutic potential of selective peroxisome proliferator-activated receptor alpha modulators (SPPARMα) for management of patients with atherogenic dyslipidemia By Heather Nelson Cortes, PhD and Kevin C Maki, PhD   Atherosclerotic cardiovascular disease (ASCVD) is associated with a significant public health burden around the world.  It is further exacerbated by chronic lifestyle-related diseases, such as visceral obesity,

Read More